SCN2A channelopathies : Mechanisms and models

Wiley Periodicals, Inc. © 2019 International League Against Epilepsy..

Variants in the SCN2A gene, encoding the voltage-gated sodium channel NaV 1.2, cause a variety of neuropsychiatric syndromes with different severity ranging from self-limiting epilepsies with early onset to developmental and epileptic encephalopathy with early or late onset and intellectual disability (ID), as well as ID or autism without seizures. Functional analysis of channel defects demonstrated a genotype-phenotype correlation and suggested effective treatment options for one group of affected patients carrying gain-of-function variants. Here, we sum up the functional mechanisms underlying different phenotypes of patients with SCN2A channelopathies and present currently available models that can help in understanding SCN2A-related disorders.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:60 Suppl 3

Enthalten in:

Epilepsia - 60 Suppl 3(2019) vom: 15. Dez., Seite S68-S76

Sprache:

Englisch

Beteiligte Personen:

Hedrich, Ulrike B S [VerfasserIn]
Lauxmann, Stephan [VerfasserIn]
Lerche, Holger [VerfasserIn]

Links:

Volltext

Themen:

Developmental and epileptic encephalopathy
Genotype-phenotype correlation
Journal Article
NAV1.2 Voltage-Gated Sodium Channel
NaV1.2 channel defect
Pathomechanisms
Research Support, Non-U.S. Gov't
Review
SCN2A channelopathies
SCN2A protein, human

Anmerkungen:

Date Completed 23.04.2020

Date Revised 23.04.2020

published: Print

Citation Status MEDLINE

doi:

10.1111/epi.14731

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM305036661